Overview
Sara Conde is an Oncologist practicing medicine in San Antonio, Texas.
Her clinical expertise encompasses Appendix Cancer, Colorectal Cancer, Lynch Syndrome, and Diffuse Large B-Cell Lymphoma (DLBCL).
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
Locations
4383 Medical Dr, San Antonio, TX 78229
University Of Texas Health Science Center At San Antonio
Andrew Brenner is an Oncologist practicing medicine in San Antonio, Texas. Dr. Brenner is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Astrocytoma, Glioblastoma, Glioma, Colonoscopy, and Endoscopy. Dr. Brenner is currently accepting new patients.
Texas Oncology - San Antonio Medical Center
Antonio Santillan-Gomez is an Oncologist practicing medicine in San Antonio, Texas. Dr. Santillan-Gomez is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Virilizing Ovarian Tumor, Ovarian Carcinosarcoma, Cervical Cancer, Salpingo-Oophorectomy, and Hernia Surgery. Dr. Santillan-Gomez is currently accepting new patients.
University Health
Virginia Kaklamani is an Oncologist practicing medicine in San Antonio, Texas. Dr. Kaklamani is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, Paget Disease of the Breast, and PIK3CA-Related Overgrowth Spectrum. Dr. Kaklamani is currently accepting new patients.
Frequently Asked Questions about Dr. Sara M. Conde
How do I make an appointment with Dr. Sara M. Conde?
You can book an appointment with Dr. Sara M. Conde by calling their office at 210-593-5700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Sara M. Conde a top-rated expert for Appendix Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sara M. Conde is classified as an Experienced expert for Appendix Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Sara M. Conde specialize in?
While Dr. Sara M. Conde is a Oncology, they have specific expertise in Appendix Cancer, Colorectal Cancer, and Lynch Syndrome. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Sara M. Conde accept my insurance?
Dr. Sara M. Conde accepts most major insurance plans, including Anthem BCBS and Humana. We recommend calling the office directly at 210-593-5700 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Appendix CancerDr. Conde isExperienced. Learn about Appendix Cancer.
- Breast CancerDr. Conde isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Conde isExperienced. Learn about Colorectal Cancer.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Conde isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Familial Colorectal CancerDr. Conde isExperienced. Learn about Familial Colorectal Cancer.
- Large-Cell Immunoblastic LymphomaDr. Conde isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.
- Lynch SyndromeDr. Conde isExperienced. Learn about Lynch Syndrome.
- Multiple MyelomaDr. Conde isExperienced. Learn about Multiple Myeloma.
- Paget Disease of the BreastDr. Conde isExperienced. Learn about Paget Disease of the Breast.
- Smoldering Multiple MyelomaDr. Conde isExperienced. Learn about Smoldering Multiple Myeloma.